Respiratory Drug Delivery Market by Formulation (Suspension Aerosols,Solution Aerosols, and Dry Powder Formulations), Device Type (Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIs) and Nebulizers), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Cystic Fibrosis) andEnd User (Hospitals & Clinics and Home Care Patients) - Global Analysis & Forecast 2020-2030
Report ID : 288 | Published Date : Jun 2020 | Pages : 160 | Region : Global | Report Code : MD-82
Respiratory Drug Delivery Market Overview and Introduction
The first-line treatment for diseases, such as cystic fibrosis, asthma, chronic bronchitis, and sinusitis, amongothers, is inhalation of the medication. The effectiveness of inhalation is related to the amount of drug deposited beyond the oropharyngeal region. It is also important to consider the size of the inhaled particles, the breathing conditions, the geometry of the airways, and the mucociliary clearance mechanisms.Respiratory drug delivery involves the inhalation of a drug formulation through the mouth and its accumulation it the lower airways.
The global respiratory drug delivery market is majorly driven by the rising incidentsof respiratory diseases globally.According to the WHO, more than 65 million people suffer from Chronic Obstructive Pulmonary Diseases (COPD) each year and more than 3 million people die from it. Moreover, theincreasing demand for home healthcare devices and the rising geriatric population are further anticipated to propel market growth during the forecast period. Air becomes unhealthy majorly due to indoor &outdoor air pollution caused by smoking tobacco, toxic particles, fumes, and allergens.This leads to an increase in the number of COPD cases, further contributing to market growth. However, the inappropriateutilization of these devices may lead to drug formulation wastage due to evaporation, which may hinder the market growth to a certain extent.
The global respiratory drug delivery market is segmented into formulation, device type, application,and end user.
Respiratory Drug Delivery Market By Formulation
Based on formulation, the market can be segmented into suspension aerosols, solution aerosols, and dry powder formulations. The dry powder formulations segment is expected to witness the highest CAGR during the forecast period owingto technological advancement aimed toward improved dosage accuracy, minimized dosage variability, and improved flow of drug particles into the lungs ofpatients, further optimizing the effectiveness of the inhaled drug.
Respiratory Drug Delivery Market By Device Type
Based on device type, the market can be segmented into Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIs), and Nebulizers. The Metered Dose Inhalers (MDIS) segmentaccounted for the largest market share owing to an increase in the number of asthma patients.Moreover, MDIS are currently the only well-known asthma treatment devices available. Also, global key players that are involved in the development of these devices are contributing to the growing implementation of this device type.
Respiratory Drug Delivery Market By Application
Based on application, the market can be segmented into ChronicObstructive Pulmonary Disease (COPD), asthma,cystic fibrosis, and others. Theasthma segmentdominated the market owing to the growing number of asthma patients worldwide.
Respiratory Drug Delivery Market By End User
Based on end user, the market can be segmented intohospitals & clinics, home care patients, and others. The hospitals & clinics segment held adominant market share owing to hospitals providingextensive treatments, care, quick reimbursements, and insurance policies dueto which patients prefer hospital pharmacies.
Respiratory Drug Delivery Market by Region
Based on region, the global Respiratory Drug Deliverymarket can be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW).North America dominated the marketowing to the rising incidentsof diseases such as COPD and asthma. This increases the demand for diagnostic devices, thereby boosting the growth of the market in thisregion.Additionally, the presence of key local players in pharmaceuticals and medical devices, advanced healthcare infrastructure, aging population, high disposable incomes, and lifestyle changes are factors contributing to the overall growth of the North America respiratory drug delivery devices market.
Respiratory Drug Delivery Market Prominent Players
Some of the key players operating in theglobal respiratory drug delivery marketinclude 3M, GlaxoSmithKline plc., AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH., Philips Respironics, Merck & Co., Inc., OMRON Healthcare, Cipla Inc., and others.